Best evidence on B-domain deletion and the immunogenicity of recombinant factor VIII

J Thromb Haemost. 2011 Nov;9(11):2325-7. doi: 10.1111/j.1538-7836.2011.04496.x.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Autoantibodies / blood*
  • Clinical Trials as Topic / statistics & numerical data*
  • Coagulants / administration & dosage*
  • Coagulants / immunology*
  • Factor VIII / administration & dosage*
  • Factor VIII / immunology*
  • Hemarthrosis / drug therapy*
  • Hemophilia A / drug therapy*
  • Hemophilia A / immunology*
  • Hemophilia A / therapy*
  • Home Infusion Therapy*
  • Humans
  • Immunogenetic Phenomena*
  • Male
  • Secondary Prevention*
  • Sucrose / administration & dosage*

Substances

  • Autoantibodies
  • Coagulants
  • Sucrose
  • Factor VIII